ArticleBlood advances2020

Effectiveness and safety of rivaroxaban compared with low-molecular-weight heparin in cancer-associated thromboembolism.

Olivia S Costa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.